Blog / Archives
New Coverage: genomics and diagnostics-Genomic Health(GHDX)
Genomic Health (GHDX) 2/4/10 Molecular Diagnostics and Genomics Public Company- Market Cap $482M Stock Price $16.5-17.5 Summary Genomic Health is a life science Company focused on the development...
Microfluidics (MFLU.OB-$0.90) -a leader in advanced nano-material processing for a variety of industries
Microfluidics (MFLU.OB-$0.90) -a leader in advanced, nano-material, processing for a variety of industries A turn-around play with value characteristics This is a "heads-up" on a special report that...
Life Science Sector Performance: ETF’s and Funds Feb 12 mos.YTD
In a volatile sell-off day involving tech stocks, the biotech world was relatively calm. Despite good news on corporate earnings and a GDP with an annual 5.7% annual growth, investors chose to take...
Biomedical stocks beat the bleak
Large Cap biomedical stocks held firm on another volatile but down day in the market driven by a host of macro and fundamental factors: earnings, Davos, Greece,China, politics, Bernanke...
Gilead Sciences revenues and profits up sharply on antiviral drugs
Gilead (GILD) shares were up 6% to $47.75 after the close as the Company announced record sales and earnings. Full Year total Revenues were $7.01B up 31% over 2008. Full Year Non-GAAP EPS were $3.06...
Amgen Earnings just OK; January effect for BIO topped out
AMGN-Top line revenue slowing One of the largest biotech companies reported earnings within estimates with full year 2009 EPS of $4.91 up 8% on Revenue of $14.6B down 2%.2010 Total Revenue is...
Waxman Power Play to squeeze Biotech for “biogenerics”
It is hard to believe but the Obama administration wants to open up a new political front at the last minute to squeeze the biotechnology industry after everyone thought the 12 year protection from...
JPMorgan Healthcare Conference 2010: Themes and News
Here are some of the broader themes and market trends gleaned from Company presentations: 1.) There is a shift from small molecule drug development to biologicals and vaccines. e.g. Pfizer (PFE) 2.)...
JPMorgan Healthcare Conference-2010 Day One-Monday January 11
Over 5000 people piled into the Westin St. Francis Hotel in San Francisco for the 28th Annual Conference. Investors, Company presenters and entrepreneurs were emboldened by good biotech sector...
JPMorgan Healthcare Conference Jan.11-14 San Francisco
We will be attending the 28th Annual JPMorgan Healthcare Conference in San Francisco and reporting on various companies and news on the Genetic Engineering News WEB site (www.genengnews.com)....